Cargando…

Letter to the editor: More data on vaccine efficacy/effectiveness of COVID-19 vaccines against asymptomatic SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Chen, Ying-Wen, Ko, Wen-Chien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414956/ https://www.ncbi.nlm.nih.gov/pubmed/34477053 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.35.2100826

Ejemplares similares

Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
por: Harder, Thomas, et al.
Publicado: (2021)

Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design
por: Moghnieh, Rima, et al.
Publicado: (2022)

Reply to the letter to the editor: “impact of SARS-CoV-2 vaccines on the nervous system”
por: Corrêa, Diogo Goulart, et al.
Publicado: (2022)

Reponse to Letter to The Editor: Regarding: Evaluation of vaccination status of health care workers for recommended vaccines and their acceptance of SARS-CoV-2 vaccines
por: Oygar, Pembe Derin, et al.
Publicado: (2022)

Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2
por: Colson, Philippe, et al.
Publicado: (2020)

Reply to the Letter to the Editor for “Parsonage-Turner syndrome after SARS-CoV-2 vaccination: A case report”
por: Öncel, Adil, et al.
Publicado: (2023)

Letter to the Editor Regarding “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
por: Finsterer, Josef
Publicado: (2022)

Letter to the Editor: Anti-SARS-CoV-2 Vaccination-Related Polyradiculitis Requires Early Diagnosis and Treatment to Improve the Outcome
por: Finsterer, Josef
Publicado: (2023)

Letter to the Editor: Before Blaming SARS-CoV-2 Infection or Vaccination for Takotsubo, Differentials Should be Ruled out
por: Finsterer, Josef, et al.
Publicado: (2022)

Response to the letter to the editor: two cases of subacute thyroiditis after different types of SARS-CoV-2 vaccination
por: Bostan, Hayri, et al.
Publicado: (2022)

Reply to the Letter to the Editor for “Rule out differentials before diagnosing SARS-CoV-2 vaccination related Parsonage-Turner syndrome”
por: Öncel, Adil, et al.
Publicado: (2023)

Letter to the editor: SARS-CoV-2 detection by real-time RT-PCR
por: Pillonel, Trestan, et al.
Publicado: (2020)

A Response to: Letter to the Editor Regarding the Article: “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
por: Drosos, Alexandros A., et al.
Publicado: (2022)

Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection
por: Bian, Jingwei, et al.
Publicado: (2020)

Severe rhabdomyolysis and SARS-CoV-2 vaccination: a reply to the letter by Dr. Josef Finsterer.: Reply to Letter to the Editor regarding our report to Dr. Finsterer.
por: Kamura, Yuya, et al.
Publicado: (2022)

Letter to the Editor: Ischemic Stroke of the Corpus Callosum after SARS-CoV-2 Vaccination
por: Finsterer, Josef, et al.
Publicado: (2021)

Letter to the Editors: “Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination” by C. Schwab et al.
por: Schirmacher, Peter, et al.
Publicado: (2023)

Letter to the editor: Measles cases among fully vaccinated persons
por: Arima, Yuzo, et al.
Publicado: (2018)

“Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety” [Response To Letter]
por: Mascellino, Maria Teresa, et al.
Publicado: (2021)

Reply to Letter to Editor: Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
por: Kamel, Walaa A., et al.
Publicado: (2021)

Neurological Side Effects of SARS-CoV-2 Vaccinations are Not Uncommon but Frequently Ignored [Letter]
por: Finsterer, Josef, et al.
Publicado: (2022)

Basic Lessons From India on Vaccination [Letter to the Editor]
por: Shamim, Thorakkal
Publicado: (2023)

Letter to the editor: Epidemiology of the SARS-CoV-2 variant Omicron BA.2 – vigilance needed
por: Huang, Jing, et al.
Publicado: (2022)

Letter to the editor: Bias in the vaccine effectiveness estimates of one-dose post-exposure prophylaxis against mpox
por: van Ewijk, Catharina E, et al.
Publicado: (2023)

Are the new SARS-CoV-2 variants resistant against the vaccine?
por: Abdalla, Mohnad, et al.
Publicado: (2021)

Response to Letter to the Editor on the article “Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination”
por: Vogrig, Alberto, et al.
Publicado: (2022)

Reply letter to the editor concerning the article ‘Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance’
por: Izquierdo-Garcia, Elsa, et al.
Publicado: (2022)

A Response Letter to: Letter to the Editor Regarding “Anti-SARS-CoV-2 Vaccination Related Polyradiculitis Requires Early Diagnosis and Treatment to Improve the Outcome: Facts and Challenges During COVID-19 Pandemic”
por: Duong-Quy, S.
Publicado: (2023)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

Response to letter to the editor “Does SARS-CoV-2 truly cause infectious myopathy?”
por: Chang, Kai Chieh
Publicado: (2021)

Author’s reply to the Letter to the Editor “The study of olfactory dysfunction in SARS-CoV-2 variants”
por: Hintschich, Constantin A., et al.
Publicado: (2022)

Reply to Letter to the Editor: “How Does SARS-CoV-2 Fragment the QRS?”
por: Halil Özdemir, İbrahim, et al.
Publicado: (2022)

Letter to the editor: Correspondence on Chinese medical personnel vaccinations
por: Sekhar, Sejal C., et al.
Publicado: (2022)

Letter to the editor on “Asymptomatic infection by SARS 2 coronavirus: Invisible but invincible” by Nikolai et al. 2020
por: Malagón-Rojas, Jeadran, et al.
Publicado: (2020)

Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia
por: Konishi, Yoshinobu, et al.
Publicado: (2022)

Letter to the Editor [Letter]
por: Félix, Sylvie
Publicado: (2021)

Letter to the editor in response to: Rotavirus vaccine administration patterns in Italy: potential impact on vaccine coverage, compliance and adherence
por: Carias, Cristina, et al.
Publicado: (2021)

Hashimoto encephalopathy after vaccination against SARS-CoV-2
por: Viscasillas Sancho, M., et al.
Publicado: (2022)

Letter to the Editor and Response
por: Wen, Dennis Y., et al.
Publicado: (2013)

Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
por: Sharun, Khan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mlpcetkhb44t9ekcslaj3h0l25